AGILENT TECHNOLOGIES INC (A) Stock Fundamental Analysis

NYSE:A • US00846U1016

123.87 USD
-1.94 (-1.54%)
At close: Feb 17, 2026
123.87 USD
0 (0%)
After Hours: 2/17/2026, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, A scores 6 out of 10 in our fundamental rating. A was compared to 58 industry peers in the Life Sciences Tools & Services industry. A has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. A has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • A had positive earnings in the past year.
  • In the past year A had a positive cash flow from operations.
  • Each year in the past 5 years A has been profitable.
  • A had a positive operating cash flow in each of the past 5 years.
A Yearly Net Income VS EBIT VS OCF VS FCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • A has a Return On Assets of 10.24%. This is amongst the best in the industry. A outperforms 89.66% of its industry peers.
  • With an excellent Return On Equity value of 19.33%, A belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 13.20%, A belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for A is in line with the industry average of 12.04%.
Industry RankSector Rank
ROA 10.24%
ROE 19.33%
ROIC 13.2%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
A Yearly ROA, ROE, ROICA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • A has a Profit Margin of 18.75%. This is amongst the best in the industry. A outperforms 93.10% of its industry peers.
  • In the last couple of years the Profit Margin of A has grown nicely.
  • A has a Operating Margin of 22.47%. This is amongst the best in the industry. A outperforms 91.38% of its industry peers.
  • A's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 52.73%, A is doing good in the industry, outperforming 65.52% of the companies in the same industry.
  • In the last couple of years the Gross Margin of A has remained more or less at the same level.
Industry RankSector Rank
OM 22.47%
PM (TTM) 18.75%
GM 52.73%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
A Yearly Profit, Operating, Gross MarginsA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • A has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • A has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, A has less shares outstanding
  • A has a better debt/assets ratio than last year.
A Yearly Shares OutstandingA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
A Yearly Total Debt VS Total AssetsA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • A has an Altman-Z score of 4.83. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
  • A has a better Altman-Z score (4.83) than 89.66% of its industry peers.
  • The Debt to FCF ratio of A is 2.91, which is a good value as it means it would take A, 2.91 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.91, A belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
  • A has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
  • A has a Debt to Equity ratio of 0.45. This is in the lower half of the industry: A underperforms 63.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.91
Altman-Z 4.83
ROIC/WACC1.24
WACC10.63%
A Yearly LT Debt VS Equity VS FCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.96 indicates that A should not have too much problems paying its short term obligations.
  • A has a Current ratio of 1.96. This is comparable to the rest of the industry: A outperforms 41.38% of its industry peers.
  • A has a Quick Ratio of 1.52. This is a normal value and indicates that A is financially healthy and should not expect problems in meeting its short term obligations.
  • A has a worse Quick ratio (1.52) than 62.07% of its industry peers.
  • The current and quick ratio evaluation for A is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.52
A Yearly Current Assets VS Current LiabilitesA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.48% over the past year.
  • The Earnings Per Share has been growing by 11.21% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 6.73% in the past year.
  • A shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.41% yearly.
EPS 1Y (TTM)5.48%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%8.9%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%9.41%

3.2 Future

  • A is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.02% yearly.
  • The Revenue is expected to grow by 6.00% on average over the next years.
EPS Next Y8.48%
EPS Next 2Y9.33%
EPS Next 3Y10.14%
EPS Next 5Y10.02%
Revenue Next Year6.39%
Revenue Next 2Y6.31%
Revenue Next 3Y6.39%
Revenue Next 5Y6%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
A Yearly Revenue VS EstimatesA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
A Yearly EPS VS EstimatesA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.20, A is valued on the expensive side.
  • 75.86% of the companies in the same industry are more expensive than A, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.16. A is around the same levels.
  • A is valuated rather expensively with a Price/Forward Earnings ratio of 20.46.
  • A's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. A is cheaper than 79.31% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, A is valued a bit cheaper.
Industry RankSector Rank
PE 22.2
Fwd PE 20.46
A Price Earnings VS Forward Price EarningsA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, A is valued a bit cheaper than 70.69% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, A is valued a bit cheaper than the industry average as 70.69% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 30.41
EV/EBITDA 19.79
A Per share dataA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates A does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of A may justify a higher PE ratio.
PEG (NY)2.62
PEG (5Y)1.98
EPS Next 2Y9.33%
EPS Next 3Y10.14%

5

5. Dividend

5.1 Amount

  • A has a yearly dividend return of 0.82%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.10, A pays a better dividend. On top of this A pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, A's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.82%

5.2 History

  • The dividend of A is nicely growing with an annual growth rate of 6.57%!
  • A has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of A decreased recently.
Dividend Growth(5Y)6.57%
Div Incr Years1
Div Non Decr Years1
A Yearly Dividends per shareA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 21.64% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
  • The dividend of A is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.64%
EPS Next 2Y9.33%
EPS Next 3Y10.14%
A Yearly Income VS Free CF VS DividendA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
A Dividend Payout.A Dividend Payout, showing the Payout Ratio.A Dividend Payout.PayoutRetained Earnings

AGILENT TECHNOLOGIES INC

NYSE:A (2/17/2026, 8:04:00 PM)

After market: 123.87 0 (0%)

123.87

-1.94 (-1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-24
Earnings (Next)02-25
Inst Owners92%
Inst Owner Change-0.54%
Ins Owners0.16%
Ins Owner Change3.03%
Market Cap35.04B
Revenue(TTM)6.95B
Net Income(TTM)1.30B
Analysts78.62
Price Target171.65 (38.57%)
Short Float %1.52%
Short Ratio2.12
Dividend
Industry RankSector Rank
Dividend Yield 0.82%
Yearly Dividend0.99
Dividend Growth(5Y)6.57%
DP21.64%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-06
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.62%
Min EPS beat(2)-1.64%
Max EPS beat(2)-1.6%
EPS beat(4)2
Avg EPS beat(4)-0.13%
Min EPS beat(4)-1.64%
Max EPS beat(4)1.56%
EPS beat(8)6
Avg EPS beat(8)0.96%
EPS beat(12)9
Avg EPS beat(12)1.07%
EPS beat(16)12
Avg EPS beat(16)1.9%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)2.3%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)2.3%
Revenue beat(8)3
Avg Revenue beat(8)0%
Revenue beat(12)5
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)0.18%
PT rev (1m)0.57%
PT rev (3m)12.78%
EPS NQ rev (1m)-0.23%
EPS NQ rev (3m)-2.84%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-1.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.83%
Valuation
Industry RankSector Rank
PE 22.2
Fwd PE 20.46
P/S 5.04
P/FCF 30.41
P/OCF 22.47
P/B 5.2
P/tB 19.22
EV/EBITDA 19.79
EPS(TTM)5.58
EY4.5%
EPS(NY)6.05
Fwd EY4.89%
FCF(TTM)4.07
FCFY3.29%
OCF(TTM)5.51
OCFY4.45%
SpS24.57
BVpS23.83
TBVpS6.45
PEG (NY)2.62
PEG (5Y)1.98
Graham Number54.7
Profitability
Industry RankSector Rank
ROA 10.24%
ROE 19.33%
ROCE 15.04%
ROIC 13.2%
ROICexc 15.95%
ROICexgc 37.3%
OM 22.47%
PM (TTM) 18.75%
GM 52.73%
FCFM 16.58%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
ROICexc(3y)16.03%
ROICexc(5y)16.51%
ROICexgc(3y)38.11%
ROICexgc(5y)42.31%
ROCE(3y)15.36%
ROCE(5y)15.95%
ROICexgc growth 3Y-8.87%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y-4.92%
ROICexc growth 5Y7.55%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.91
Debt/EBITDA 1.65
Cap/Depr 141.32%
Cap/Sales 5.86%
Interest Coverage 15.46
Cash Conversion 84.32%
Profit Quality 88.41%
Current Ratio 1.96
Quick Ratio 1.52
Altman-Z 4.83
F-Score5
WACC10.63%
ROIC/WACC1.24
Cap/Depr(3y)132.79%
Cap/Depr(5y)109.81%
Cap/Sales(3y)5.34%
Cap/Sales(5y)4.65%
Profit Quality(3y)104.6%
Profit Quality(5y)100.47%
High Growth Momentum
Growth
EPS 1Y (TTM)5.48%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%8.9%
EPS Next Y8.48%
EPS Next 2Y9.33%
EPS Next 3Y10.14%
EPS Next 5Y10.02%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%9.41%
Revenue Next Year6.39%
Revenue Next 2Y6.31%
Revenue Next 3Y6.39%
Revenue Next 5Y6%
EBIT growth 1Y-0.19%
EBIT growth 3Y-1.19%
EBIT growth 5Y12.72%
EBIT Next Year27.4%
EBIT Next 3Y14.45%
EBIT Next 5Y11.39%
FCF growth 1Y-16.1%
FCF growth 3Y4.11%
FCF growth 5Y7.51%
OCF growth 1Y-10.97%
OCF growth 3Y5.92%
OCF growth 5Y11.1%

AGILENT TECHNOLOGIES INC / A FAQ

Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to A.


Can you provide the valuation status for AGILENT TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 4 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.


Can you provide the profitability details for AGILENT TECHNOLOGIES INC?

AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.


What is the valuation of AGILENT TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AGILENT TECHNOLOGIES INC (A) is 22.2 and the Price/Book (PB) ratio is 5.2.


Can you provide the dividend sustainability for A stock?

The dividend rating of AGILENT TECHNOLOGIES INC (A) is 5 / 10 and the dividend payout ratio is 21.64%.